Related Experiment Video
Updated: Feb 3, 2026

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
Published on: March 14, 2014
Inhibitory effects of Schisandrin B on human prostate cancer cells
Moussa Ide Nasser1, Tingyu Han1, Salah Adlat1
1Colleges of Life Science and Technology, Dalian University, Dalian Economical Technological Development Zone, Liaoning 116622, P.R. China.
Abstract:
Prostate cancer is a serious affliction worldwide. Although much progress has been made in the study of prostate cancer prevention and treatment, less attention has been paid to the molecular mechanism of the disease. The molecular arrangement by which Schisandrin B (Sch B) induces human prostate cancer cytotoxicity was comprehensively examined in the present study. As indicated by the results of flow cytometric and western blot analysis, Sch B could inhibit prostate cancer cell proliferation and promote DU145 and LNCaP cell apoptosis and S‑phase cell arrest. Moreover, real‑time PCR, flow cytometry and western blot result revealed that the cell apoptosis process induced by Sch B in LNCaP cells was associated with its capacity to generate oxidative stress, its inhibition of androgen receptor and the phosphorylation of PI3K/AKT and STA3/JAK2. The data from the present study demonstrated the antitumor effects and the potential pharmacological application of Sch B as an efficient drug for prostate cancer.
Insights
Schisandrin B (Sch B) effectively inhibits prostate cancer cell growth and induces cancer cell death. This natural compound shows potential as a novel therapeutic agent for prostate cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Prostate cancer remains a significant global health concern.
- Understanding the molecular mechanisms of prostate cancer is crucial for developing effective treatments.
- Schisandrin B (Sch B) is a natural compound with potential anti-cancer properties.
Purpose of the Study:
- To comprehensively examine the molecular mechanisms by which Schisandrin B (Sch B) induces cytotoxicity in human prostate cancer cells.
- To investigate the effects of Sch B on prostate cancer cell proliferation, apoptosis, and cell cycle progression.
- To elucidate the signaling pathways involved in Sch B-induced apoptosis in prostate cancer cells.
Main Methods:
- Flow cytometry was used to analyze cell apoptosis and cell cycle arrest.
- Western blot analysis was employed to assess protein expression and phosphorylation levels.
- Real-time PCR was utilized to investigate gene expression related to apoptosis and signaling pathways.
Main Results:
- Schisandrin B (Sch B) inhibited proliferation and induced apoptosis and S-phase arrest in DU145 and LNCaP prostate cancer cells.
- Sch B-induced apoptosis in LNCaP cells was linked to oxidative stress generation.
- Sch B treatment inhibited androgen receptor signaling and the phosphorylation of PI3K/AKT and STAT3/JAK2 pathways.
Conclusions:
- Schisandrin B (Sch B) exhibits significant antitumor effects against prostate cancer cells.
- The molecular mechanisms involve oxidative stress, androgen receptor inhibition, and modulation of PI3K/AKT and STAT3/JAK2 pathways.
- Schisandrin B (Sch B) holds potential as a pharmacological agent for prostate cancer treatment.
Related Concept Videos
Excitatory and Inhibitory Effects of Neurotransmitters
Buffer Effectiveness
The buffer capacity is the amount of acid or base that can be added to a given volume...
Framing Effects
Cancer Cell Migration through Invadopodia
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Biological Effects of Radiation

